Featured Trial

Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder

Study Identifier:

405-201-00062

ClinicalTrials.gov Identifier:

NCT05536414

EudraCT Identifier:

N/A

Sponsor:

Otsuka Pharmaceutical Development & Commercialization, Inc.

Study Contact Information:

844-687-8522 or [email protected]

Recruiting

Subscribe to Updates See if You Qualify

Therapeutic Area

Depression

Study Drug

Drug: Centanafadine

Drug: Escitalopram

Drug: Placebo

Estimated Enrollment

336

Phase

Phase 2

Type

Interventional

Trial Dates

Sep 2022 - May 2025

Study Locations

Location

Status

Location

Yuma CNS Research

Yuma, Arizona, United States, 85365-4905

Status

Active, not recruiting

Location

SanRo Clinical Research Group LLC

Bryant, Arkansas, United States, 72022-9252

Status

Terminated

Location

Behavioral Research Specialists-California-Irvine

Glendale, California, United States, 91206-4282

Status

Recruiting

Location

Sunwise Clinical Research, LLC - Lafayette - IVY - PPDS

Lafayette, California, United States, 94549

Status

Recruiting

Location

OM Research LLC - Lancaster - ClinEdge - PPDS

Lancaster, California, United States, 93534-5504

Status

Active, not recruiting

Location

Synergy Research Centers - SRC - ERG - PPDS

Lemon Grove, California, United States, 91945-2956

Status

Active, not recruiting